Topline data were announced from two phase 3 studies evaluating setrusumab in patients with osteogenesis imperfecta.

A newly discovered receptor switch that boosts bone growth could transform how we treat osteoporosis, by stimulating the body’s own bone-building machinery using a targeted drug and even mechanical ...

(A, B) ALP staining and activity detection were performed after treating cells with APPswe or BMP2 for 5 days or 7 days. (C, D) ARS staining and semiquantitative analysis were used to detect calcium ...

A recent study identifies Neural EGFL-like 2 (NELL2), a secreted protein, as a key regulator of bone homeostasis, offering potential therapeutic applications for osteoporosis. NELL2 promotes ...

Please provide your email address to receive an email when new articles are posted on . Ceramic biomaterial remodeled into cancellous bone at 3 months postoperatively and densified at 6 months ...

Sustained hypoxia affects orthodontic tooth movement (OTM) by altering osteoclast and osteoblast differentiation, report researchers from the Institute of Science Tokyo, Japan. Hypoxic conditions ...

When a house catches on fire, we assume that a smoke alarm inside will serve one purpose and one purpose only: warn the ...